CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Chief Financial Officer acquired 18,386 shares (grant or award)
- 4 Grant or award CEO, Chairman of the Board acquired 170,300 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 100,000 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- CT ORDER Other Confidential Order
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 24 of 62 · 1,225 filings